The first premixed autoinjector for very low blood sugar1

Easy-to-use, reliable administration1,2

Gvoke HypoPen™ is the first autoinjector for very low blood sugar. It is premixed and ready-to-go, with no visible needle. That means it's easy‑to‑use!1,3

Gvoke HypoPen™ (glucagon injection)
Gvoke HypoPen1
  • Premixed and ready-to-go, so it's easy-to-use2
  • Simple 2-step administration4
  • No visible needle
  • No refrigeration required

Gvoke should be stored at room temperature (68°F-77°F)1
Gvoke comes in 2 premeasured doses for:1,*
  • adolescents and adults (1.0 mg)
  • kids (0.5 mg)

*Kids younger than 12 who weigh at least 100 pounds may be prescribed the 1.0 mg dose.

Gvoke™ (glucagon injection) two-pack pouches
Gvoke comes in a
convenient 2‑pack

Keep one with you and the other at home, school, or work. Put it in a spot where you can get to it quickly. Make sure you tell others where you keep your Gvoke, just in case you can't get to it yourself. Also, be sure to tell them that Gvoke needs to stay in its sealed foil pouch until they are sure that they're going to use it.1

Looking for
additional information?

Download the Frequently Asked Questions for general information.

References: 1. Gvoke [prescribing information]. Chicago, IL: Xeris Pharmaceuticals, Inc. 2. Valentine V, Newswanger B, Prestrelski S, Andre AD, Garibaldi M. Human factors usability and validation studies of a glucagon autoinjector in a simulated severe hypoglycemia rescue situation. Diabetes Technol Ther. 2019;21(9):522‑530. 3. U.S. Food and Drug Administration. Search results for "glucagon." Drugs@FDA: FDA approved drug products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process. Accessed September 13, 2019. 4. Gvoke HypoPen [instructions for use]. Chicago, IL: Xeris Pharmaceuticals, Inc.